Valuation: Labcorp Holdings Inc.

Market Cap 30.12B 27.01B 24.89B 22.6B 42.78B 2,824B 43.97B 298B 119B 1,513B 113B 111B 4,782B P/E 2026 *
27.3x
P/E 2027 * 24.6x
Enterprise Value 35.28B 31.64B 29.16B 26.48B 50.12B 3,308B 51.52B 349B 139B 1,772B 132B 130B 5,603B EV / Sales 2026 *
2.38x
EV / Sales 2027 * 2.22x
Free-Float
99.65%
Yield 2026 *
0.78%
Yield 2027 * 0.79%
1 day-0.26%
1 week+4.79%
Current month+2.63%
1 month+18.81%
3 months+15.43%
6 months+45.95%
Current year+47.83%
1 week 355.63
Extreme 355.63
373.76
1 month 310.11
Extreme 310.11
373.76
Current year 245
Extreme 245
373.76
1 year 245
Extreme 245
373.76
3 years 191.97
Extreme 191.97
373.76
5 years 191.97
Extreme 191.97
373.76
10 years 98.02
Extreme 98.02
373.76
Date Insider Type Main position Quantity % Market Cap. Importance
03/11/26 Sell

EVP and President, Diagnostics

-306 0.0004%
02/11/26 Tax

EVP and President, Diagnostics

-194 0.0002%
02/11/26 Tax

Chief Technology Officer

-118 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.26%+4.79%+42.03%+81.11% 30.12B
+4.41%-2.63%+14.79%+31.52% 114B
-0.09%+8.98%+9.82%+116.66% 105B
-2.62%-19.72%+50.98%+567.48% 45.24B
+0.64%+9.55%+11.61%+113.54% 33.58B
-0.47%+4.61%+40.22%+94.58% 28.43B
+0.44%+8.84%+49.10%+439.64% 23.1B
+0.05%+0.56%-17.71%-17.71% 20.02B
-0.65%-1.16%-7.35%+30.12% 16.86B
+4.83%+3.79%+115.94% - 15.1B
Average +0.58%+1.52%+30.94%+161.88% 43B
Weighted average by Cap. +1.01%+1.11%+23.70%+145.96%

Financials

2026 *2027 *
Net sales 14.83B 13.3B 12.25B 11.13B 21.06B 1,390B 21.65B 147B 58.46B 745B 55.64B 54.46B 2,355B 15.63B 14.01B 12.91B 11.73B 22.2B 1,465B 22.82B 155B 61.61B 785B 58.64B 57.4B 2,481B
Net income 1.11B 997M 919M 834M 1.58B 104B 1.62B 11B 4.38B 55.83B 4.17B 4.08B 177B 1.22B 1.09B 1.01B 914M 1.73B 114B 1.78B 12.05B 4.8B 61.17B 4.57B 4.47B 193B
Net Debt 5.17B 4.64B 4.27B 3.88B 7.34B 485B 7.55B 51.15B 20.38B 260B 19.4B 18.99B 821B 4.59B 4.12B 3.8B 3.45B 6.53B 431B 6.71B 45.46B 18.11B 231B 17.24B 16.88B 730B
Projected Income Statement - Annual - Labcorp Holdings Inc.
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
66,385
Date Price Change Volume
10/11/26 US$370.88 -0.26% 510,426
09/11/26 US$371.83 +1.43% 797,777
06/11/26 US$366.57 +0.90% 610,114
05/11/26 US$363.30 -1.22% 775,272
04/11/26 US$367.79 +3.92% 809,673
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Labcorp Holdings Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
370.88USD
Average target price
390.06USD
Spread / Average Target
+5.17%